Open Access

Utilization of lung cancer cell lines for the study of lung cancer stem cells (Review)

  • Authors:
    • Yuyi Wang
    • Ming Jiang
    • Chi Du
    • Yang Yu
    • Yanyang Liu
    • Mei Li
    • Feng Luo
  • View Affiliations

  • Published online on: March 14, 2018     https://doi.org/10.3892/ol.2018.8265
  • Pages: 6791-6798
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Lung cancer is one of the most lethal types of cancer, and its poor prognosis is primarily due to drug resistance and cancer recurrence. As it is associated with a low five‑year survival rate, lung cancer stem cells (LCSCs) have been the subject of numerous recent studies. For these studies of LCSCs, lung cancer cell lines are more commonly used than lung cancer tissues obtained from patients, as they are easier to acquire. The methods utilized for the identification of LCSCs from lung cancer cell lines include fluorescence activated cell sorting (FACS), magnetic activated cell sorting (MACS), sphere‑forming assay and bacterial surface display library screening. As LCSCs have certain proteins expressed on the surface (CD133, CD44 and CD24) or in the cytoplasm (ALDH and ABCG2), which may act as specific markers, the most frequently used technique to identify and obtain LCSCs is FACS. The current lack of recognized biomarkers in LCSCs makes the identification of LCSCs problematic. Furthermore, the various proportions of LCSCs in specific cell lines, as revealed by numerous previous studies, may cause the LCSC model to be questioned with regard to whether the utilization of certain lung cancer cell lines is dependable for LCSC studies. The current review focuses on lung cancer cell lines that are used for the study of LCSCs and the methods available to identify LCSCs with various markers. The present study also aimed to determine the proportion of LCSCs present in specific cell lines reported by various studies, and to discuss the suitability of specific lung cancer cell lines for the study of LCSCs.
View Figures
View References

Related Articles

Journal Cover

May-2018
Volume 15 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang Y, Jiang M, Du C, Yu Y, Liu Y, Li M and Luo F: Utilization of lung cancer cell lines for the study of lung cancer stem cells (Review). Oncol Lett 15: 6791-6798, 2018.
APA
Wang, Y., Jiang, M., Du, C., Yu, Y., Liu, Y., Li, M., & Luo, F. (2018). Utilization of lung cancer cell lines for the study of lung cancer stem cells (Review). Oncology Letters, 15, 6791-6798. https://doi.org/10.3892/ol.2018.8265
MLA
Wang, Y., Jiang, M., Du, C., Yu, Y., Liu, Y., Li, M., Luo, F."Utilization of lung cancer cell lines for the study of lung cancer stem cells (Review)". Oncology Letters 15.5 (2018): 6791-6798.
Chicago
Wang, Y., Jiang, M., Du, C., Yu, Y., Liu, Y., Li, M., Luo, F."Utilization of lung cancer cell lines for the study of lung cancer stem cells (Review)". Oncology Letters 15, no. 5 (2018): 6791-6798. https://doi.org/10.3892/ol.2018.8265